Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Xenometrix AG
Helicon Therapeutics seeks drugs to enhance long-term memory based on the molecular genetics of cognition.
Thanks to genomics, combinatorial chemistry, and high-throughput screening, pharmaceutical companies have more drug leads than ever. But which are the drugs? Start-up firms with faster, smarter approaches to preclinical testing may help sort out the answers. Information technology will play a key role in lead optimization as new firms with simulation software are helping drug developers plot development strategies earlier than ever.